Lv4
670 积分 2025-02-02 加入
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study
19小时前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
20小时前
已完结
Abstract 3832: Fluid-overload associated large B-cell lymphoma and determinants of outcomes: Analysis of a pooled database
15天前
已完结
Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis
16天前
已关闭
Genetic characteristics of primary bone marrow large B-cell lymphoma
16天前
已完结
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study
21天前
已完结
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
21天前
已完结
Azacitidine–Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia
26天前
已完结
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy
2个月前
已完结
Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia
2个月前
已完结
皖公网安备34019202002308
